These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37. [A clinical analysis of micafungin treatment of pulmonary invasive fungal infection in pediatric patients with acute leukemia or post hematopoietic stem cells transplantation]. Huang K; Qiu KY; Deng LL; Fang JP; Li Y; Guo HX; Zhou DH Zhonghua Er Ke Za Zhi; 2017 Nov; 55(11):844-847. PubMed ID: 29141316 [No Abstract] [Full Text] [Related]
38. Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study. Cordonnier C; Rovira M; Maertens J; Olavarria E; Faucher C; Bilger K; Pigneux A; Cornely OA; Ullmann AJ; Bofarull RM; de la Cámara R; Weisser M; Liakopoulou E; Abecasis M; Heussel CP; Pineau M; Ljungman P; Einsele H; ; Haematologica; 2010 Oct; 95(10):1762-8. PubMed ID: 20634495 [TBL] [Abstract][Full Text] [Related]
39. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Bodey GP; Anaissie E; Gutterman J; Vadhan-Raj S Clin Infect Dis; 1993 Oct; 17(4):705-7. PubMed ID: 8268354 [TBL] [Abstract][Full Text] [Related]
40. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]